Sanofi-Aventis on Access to Medicines

April 15, 2005

Jean-Francois Dehecq, Chairman and CEO of Sanofi-Aventis, set out the guiding principles of the group's policies on Access to Medicines at the BioVision conference.

The Group has identified 6 therapeutic areas for which concrete solutions can be envisioned: five curative therapeutic fields - malaria, leishmaniasis, sleeping sickness, tuberculosis and epilepsy - as well as the preventive field of vaccines.

Disclaimer

CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.